METSA TISSUE AS
Score · fiscal year 2025
44of 100
How to read this: the company is ahead of 40 % of small companies in the same sector in 2025. What does this mean?
Rank: 23,725 of 38,670 · Handel
Profile
Cheetah · Sprinter
High profitability, lower solidity
Position against comparable companies in 2025, not a verdict on the company. Based on profitability 82 and solidity 15 out of 100 among small companies in the same sector in 2025. Methodology
Against the sector
METSA TISSUE AS is 6 points below the median for small companies in the same sector in 2025.
Median score 50 among 36,110 companies.
Against small companies in the same sector in 2025: operating margin 14.1% (median 2.5%) and equity ratio 5.7% (median 38.3%).
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 31 MNOK | 3 MNOK |
| Operating margin | 14.1% | 2.5% |
| Profit margin | 16.0% | 2.2% |
| Return on assets | 22.7% | 4.0% |
| Equity ratio | 5.7% | 38.3% |
| Debt-to-equity | 16.47 | 0.99 |
| Current ratio | 1.06 | 1.70 |
| Revenue growth | −19.6% | 3.5% |
| Revenue per employee | 2.36 MNOK | 1.62 MNOK |
The median and “ahead of” refer to small companies in the same sector in 2025. The bar shows the share of companies the figure is ahead of.
With an index of 44, METSA TISSUE AS does better than 40% of small companies in the same sector (36,579 companies) in 2025.
Score 2023–2025
- METSA TISSUE AS
- Median: small companies in the same sector
METSA TISSUE AS has a score of 44 for 2025, rank 23,725 of 38,670 in the sector.
Strongest: Profitability: percentile 82 against peers, operating margin 14.1% against a median of 2.5%.
Weakest: Solidity: percentile 15 against peers, equity ratio 5.7% against a median of 38.3%. Growth: percentile 18 against peers, revenue growth −19.6% against a median of 3.5%.
Worth a closer look
- The equity ratio is very low. Could the company absorb a bad year, and does it need more equity? Based on: equity ratio 5.7% (median 38.3%).
- What lies behind weak solidity, and will it last?
- What lies behind weak growth, and will it last?
Written by fixed rules from the figures. Describes the figures, does not explain causes. Not investment or financial advice. How the summary is made
What the numbers say
METSA TISSUE AS had an operating margin of 14.1% and an equity ratio of 5.7% in 2025, and ranks 23,725 of 38,670 in Handel.
From 2024 to 2025: the equity ratio fell from 22.1% to 5.7% and revenue fell by 20%.
This text is generated automatically from the 2025 accounts.
Three simple methods
The methods give between 1 MNOK and 38 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 10.0 | 38 MNOK |
| EV/EBIT | 8.0 | 35 MNOK |
| P/B | 1.0 | 1 MNOK |
A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation
Worth a closer look
- watch
The equity ratio is very low. Could the company absorb a bad year, and does it need more equity?
Based on: Equity ratio 5.7% (median 38.3%).
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Data quality
No anomalies found in the figures.
Scenario analysis: the sector's weakest year
We have no accounts for 2017, the sector's weakest year, for this company.
The sector's weakest year was 2017, with a median operating margin of −65.6%. Based on the 11 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
What the score is made of
| Profitability | 82 | weight 30% |
|---|---|---|
| Solidity | 15 | weight 25% |
| Liquidity | 28 | weight 15% |
| Growth | 18 | weight 15% |
| Consistency | 59 | weight 15% |
Durability: 50 (average over 3 years)
Index version 2. Data completeness 100%: the share of the weights that had data.
Questions and answers
How profitable is METSA TISSUE AS?
The operating margin was 14.1% in 2025, against a median of 2.5% among small companies in the same sector. Return on assets was 22.7%.
How solid is METSA TISSUE AS?
The equity ratio was 5.7% in 2025 (median 38.3%). Debt-to-equity was 16.47 (median 0.99).
What is the liquidity of METSA TISSUE AS like?
The current ratio was 1.06 in 2025 (median 1.70).
How does METSA TISSUE AS compare in Handel?
METSA TISSUE AS ranks 23,725 of 38,670 in Handel for 2025. Among companies of the same size (small companies) it ranks 22,130 of 36,579. Revenue changed by −19.6% from the year before.
Group accounts
The company is registered as part of a group, but we have no group accounts for it. Group accounts are filed by the parent company, and open data does not say which company that is.
Read the figures with care: a company in a group can look strong because of group contributions, or weak because dividends go up to the parent. The figures are indications, not the full picture.
We do not show the group structure, because open data does not say who owns whom.
From the Central Coordinating Register
- Org. no.
- 913524683
- Legal form
- AS · part of a group
- Sector
- Handel (46.150)
- Size tier
- small
- Employees
- 13 registered 10 October 2026
- Founded
- 17 October 1962 64 years in operation
- Share capital
- 0.60 MNOK
- Business address
- 4. etasje, Drammensveien 147, 0277 OSLO
- Municipality
- Oslo rank 63–221 of 357 in Norway
- Latest accounts filed
- 2025
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
- Chair of the board
- Carl Johan Lekman
- Board member
- Marjo Katriina Pekkala
- Board member
- Terhi Talvikki Ilvonen
- Auditor
- KPMG AS
- Accountant
- TMF NORWAY AS
Source: Central Coordinating Register, fetched 29 October 2026. Only names are shown.
Owners and shareholdings will appear here once the shareholder data extract is in place.
Coming · not built yet
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Figures last fetched 26 October 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | 51 | 55 | 44 | |
| Rank | 16,811 | 15,371 | 23,725 | |
| Operating margin | 13.0% | 11.8% | 14.1% | |
| Return on assets | 28.3% | 33.3% | 22.7% | |
| Equity ratio | 16.6% | 22.1% | 5.7% | |
| Current ratio | 1.20 | 1.28 | 1.06 | |
| Revenue growth | – | −2.2% | −19.6% |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 39.0 MNOK | 38.2 MNOK | 30.7 MNOK |
| Operating profit | 5.1 MNOK | 4.5 MNOK | 4.3 MNOK |
| Profit before tax | 5.9 MNOK | 5.2 MNOK | 4.9 MNOK |
| Net profit | 4.5 MNOK | 4.0 MNOK | 3.8 MNOK |
| Financial expenses | 0.1 MNOK | 0.0 MNOK | – |
| Total assets | 21.0 MNOK | 15.6 MNOK | 21.7 MNOK |
| Current assets | 21.0 MNOK | 15.6 MNOK | 21.7 MNOK |
| Equity | 3.5 MNOK | 3.5 MNOK | 1.2 MNOK |
| Retained earnings | 2.9 MNOK | 2.9 MNOK | 0.6 MNOK |
| Total liabilities | 17.5 MNOK | 12.2 MNOK | 20.4 MNOK |
| Current liabilities | 17.5 MNOK | 12.2 MNOK | 20.4 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 26 October 2026, accounts id 6931348.
Further
Similar companies
- HEAD NORWAY AS index 44, rank 23,726 · compare
- BOTANICA BLOMSTER AS index 44, rank 23,727 · compare
- AUTO C AS index 44, rank 23,728 · compare
- VITIS MOESTUE AS index 44, rank 23,729 · compare
- KARA IMPORT AS index 44, rank 23,731 · compare